Neurowave Medical TechnologiesTM (NMT) is a privately held Chicago-based neuroscience company that develops, manufactures, and commercializes transdermal neuromodulation devices for the treatment of a wide range of acute and chronic clinical conditions.
Health care professionals, patients and payers are increasingly seeking safe therapeutic alternatives that improve efficacy without drug-related side effects. NMT’s mission is to prevent or eliminate patients’ suffering with innovation by using our transdermal neuromodulation technology platform as the non-drug therapeutic solution
Our goal is to become the “First Line” and “Best in Class” option vs. current pharmaceutical treatments for the treatment of acute and chronic conditions.
NMT™ was founded in 2007 with the acquisition of Woodside Biomedical, Inc., a wholly-owned subsidiary of Abbott Laboratories.
